Journal of Neurogastroenterology and Motility : eISSN 2093-0887 / pISSN 2093-0879

Table. 1.

Comparative Analysis of Hospitalization Characteristics for Gastroparesis With and Without Obesity in the United States From 2007-2017

Variable Obese gastroparesis hospitalizations Non-obese gastroparesis hospitalizations P-value
Total number of hospitalizations (n) 140 293 879 950
Proportions of hospitalizations 13.75% 86.25%
Mean age (yr) 51.93 50.84 < 0.001
Age groups (yr) < 0.001
18-34 18 263 (13.02%) 196 276 (22.31%)
35-49 43 281 (30.85%) 227 723 (25.88%)
50-64 49 467 (35.26%) 242 506 (27.56%)
65-79 25 458 (18.15%) 151 903 (17.26%)
≥ 80 3824 (2.73%) 61 541 (6.99%)
Gender < 0.001
Male 33 504 (23.89%) 313 503 (35.64%)
Female 106 759 (76.11%) 566 176 (64.36%)
Race < 0.001
White 81 938 (60.88%) 523 049 (63.18%)
Black 34 304 (25.49%) 182 146 (22.00%)
Hispanic 13 510 (10.04%) 84 499 (10.21%)
Asian 1061 (0.79%) 12 982 (1.57%)
Native American 1139 (0.85%) 6048 (0.73%)
Other 2638 (1.96%) 19 209 (2.32%)
Charlson comorbidity index < 0.001
CCI = 0 17 813 (12.70%) 208 272 (23.67%)
CCI = 1 17 986 (12.82%) 128 304 (14.58%)
CCI = 2 18 036 (12.86%) 111 724 (12.70%)
CCI ≥ 3 86 458 (61.63%) 431 649 (49.05%)
Hospital Region < 0.001
Northeast 17 505 (12.48%) 122 823 (13.96%)
Midwest 33 989 (24.23%) 183 481 (20.85%)
South 63 674 (45.39%) 394 522 (44.83%)
West 25 126 (17.91%) 179 124 (20.36%)
Hospital bed-size 0.016
Small 22 829 (16.29%) 147 623 (16.83%)
Medium 42 071 (30.03%) 252 596 (28.80%)
Large 75 206 (53.68%) 476 896 (54.37%)
Hospital location and teaching status < 0.001
Rural 11 912 (8.50%) 96 455 (11.00%)
Urban non-teaching 39 483 (28.18%) 269 592 (30.74%)
Urban teaching 88 711 (63.32%) 511 067 (58.27%)
Expected primary payer < 0.001
Medicare 66 823 (47.70%) 384 925 (43.81%)
Medicaid 28 598 (20.41%) 185 516 (21.12%)
Private 35 753 (25.52%) 227 472 (25.89%)
Self-pay 5568 (3.97%) 53 711 (6.11%)
Other 3359 (2.40%) 26 905 (3.06%)
Median household income (quartile) < 0.001
1st (0-25th) 51 003 (36.91%) 300 524 (34.74%)
2nd (26-50th) 37 345 (27.02%) 229 468 (26.53%)
3rd (51-75th) 31 140 (22.53%) 195 688 (22.62%)
4th (76-100th) 18 709 (13.54%) 139 360 (16.11%)
Co-morbidities
Diabetes Mellitus type 1 9121 (6.50%) 136 360 (15.50%) < 0.001
Diabetes Mellitus type 2 89 535 (63.82%) 300 118 (34.11%) < 0.001
Hypertension 59 937 (42.72%) 298 555 (33.93%) < 0.001
Myocardial infarction 3074 (2.19%) 14 456 (1.64%) < 0.001
Cardiomyopathy 4882 (3.48%) 21 831 (2.48%) < 0.001
Congestive heart failure 30 929 (22.05%) 106 041 (12.05%) < 0.001
Atrial fibrillation 9474 (6.75%) 44 405 (5.05%) < 0.001
Dyslipidemia 53 588 (38.20%) 202 383 (23.00%) < 0.001
Anemia 48 157 (34.33%) 282 604 (32.12%) < 0.001
Peripheral vascular disease 5793 (4.13%) 32 990 (3.75%) 0.003
Chronic kidney disease 43 035 (30.67%) 209 150 (23.77%) < 0.001
Acute kidney injury 29 653 (21.14%) 159 218 (18.09%) < 0.001
Chronic obstructive pulmonary disease 24 245 (17.28%) 98 537 (11.20%) < 0.001
Malnutrition 7202 (5.13%) 92 472 (10.51%) < 0.001

CCI, Charlson comorbidity index.

J Neurogastroenterol Motil 2022;28:655~663 https://doi.org/10.5056/jnm21232
© J Neurogastroenterol Motil